Skip to main content

Table 1 Comparison of key characteristics for patients clinically diagnosed with or without sciatica. All figures are frequencies (percentages) unless stated otherwise as mean (SD)

From: Inflammatory biomarkers do not distinguish between patients with sciatica and referred leg pain within a primary care population: results from a nested study within the ATLAS cohort

Characteristics

Clinically defined sciatica

n = 93

Referred pain

n = 26

MRI + ve

(n = 44)

MRI –ve

(n = 49)

 

Socio-demographics

 Age (years), mean (SD)

55.2 (11.7)

50.3 (14.7)

49.5 (11.1)

 Female gender, N (%)

24 (55)

32 (65)

17 (65)

 BMI, mean (SD)

30.8 (6.3)

29.5 (6.2)

32.5 (8.2)

 Current smoker, N (%)

17 (39)

14 (28)

9 (34)

Pain

 RMDQ disability score (0–23), mean (SD)

12.5 (5.1)

11.8 (6.0)

11.8 (6.8)

 Back pain intensity NRS, mean (SD)

6.6 (2.3)

6.7 (2.2)

6.9 (2.3)

 Leg pain intensity, NRS, mean (SD)

6.4 (2.4)

6.1 (2.4)

7.0 (2.4)

 Pain below knee, N (%)

30 (71)

28 (61)

21 (84)

 Leg pain is worse, N (%)

21 (49)

22 (45)

16 (61)

Duration of current symptomsa

Back pain

 Back pain< 6 weeks, N (%)

15 (36)

14 (29)

7 (27)

 Back pain 6–12 weeks, N (%)

12 (29)

8 (17)

7 (27)

 Back pain > 3 months, N (%)

15 (36)

26 (54)

12 (46)

Leg pain

 Leg pain< 6 weeks, N (%)

17 (40)

15 (33)

8 (32)

 Leg pain 6–12 weeks, N (%)

15 (36)

9 (20)

8 (32)

 Leg pain> 3 months, N (%)

10 (24)

22 (48)

9 (36)

  1. aThere was a small proportion of missing data for symptom duration